This compound is primarily utilized in the field of pharmaceutical research and development. It serves as a key intermediate in the synthesis of various bioactive molecules, particularly those targeting neurological and psychiatric disorders. Its structure is often employed in the creation of nootropic agents, which are compounds designed to enhance cognitive functions such as memory and learning. Additionally, it is used in the preparation of chiral building blocks for the development of enantiomerically pure drugs, ensuring higher specificity and efficacy in therapeutic applications. The compound’s pyrrolidinone moiety is particularly valuable in designing inhibitors for enzymes involved in neurodegenerative diseases, making it a significant component in drug discovery pipelines.